{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:03:15Z","timestamp":1779328995368,"version":"3.51.4"},"reference-count":176,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.tripleo.2006.12.008","type":"journal-article","created":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T22:22:25Z","timestamp":1173392545000},"page":"642-654","source":"Crossref","is-referenced-by-count":71,"title":["Erythema multiforme and related disorders"],"prefix":"10.1016","volume":"103","author":[{"given":"Khalid A.","family":"Al-Johani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tripleo.2006.12.008_bib1","first-page":"359","article-title":"Herpes simplex-associated erythema multiforme (HAEM): a clinical therapeutic dilemma","volume":"21","author":"Katz","year":"1999","journal-title":"Pediatr Dent"},{"key":"10.1016\/j.tripleo.2006.12.008_bib2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Severe cutaneous adverse reactions","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib3","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archderm.131.11.1268","article-title":"Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome","volume":"131","author":"Cote","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archderm.131.5.539","article-title":"Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes","volume":"131","author":"Assier","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cden.2004.08.003","article-title":"Erythema multiforme: a review and contrast from Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"49","author":"Williams","year":"2005","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.tripleo.2006.12.008_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.129.1.92","article-title":"Clincal classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0733-8635(18)30925-2","article-title":"Erythema multiforme","volume":"3","author":"Huff","year":"1985","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.tripleo.2006.12.008_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0190-9622(83)80003-6","article-title":"Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes","volume":"8","author":"Huff","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1529-8019.2002.01551.x","article-title":"Treatment of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis","volume":"15","author":"Rappersberger","year":"2002","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.tripleo.2006.12.008_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1346-8138.1989.tb01281.x","article-title":"Erythema multiforme in children: unusual clinical features with seasonal occurrence","volume":"16","author":"Sakurai","year":"1989","journal-title":"J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00006454-198205000-00005","article-title":"Stevens-Johnson syndrome in children","volume":"1","author":"Ginsburg","year":"1982","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/j.tripleo.2006.12.008_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1040-0486(06)80004-9","article-title":"Erythema multiforme","volume":"2","author":"Brice","year":"1990","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1542\/pir.11-7-217","article-title":"Erythema multiforme: a review of its characteristics, diagnostic criteria, and management","volume":"11","author":"Hurwitz","year":"1990","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.tripleo.2006.12.008_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1468-3083.2000.00053.x","article-title":"Erythema multiforme along Blaschko\u2019s lines","volume":"14","author":"Micalizzi","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0030-4220(89)90299-5","article-title":"Oral erythema multiforme clinical observations and treatment of 95 patients","volume":"67","author":"Lozada-Nur","year":"1989","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0733-8635(02)00062-1","article-title":"Oral manifestations of erythema multiforme","volume":"21","author":"Ayangco","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.tripleo.2006.12.008_bib17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0190-9622(97)80009-6","article-title":"Target lesions on the lips: childhood herpes simplex associated with erythema multiforme mimics Stevens-Johnson syndrome","volume":"37","author":"Weston","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1601-0825.2005.01141.x","article-title":"Mucosal disease series","volume":"11","author":"Farthing","year":"2005","journal-title":"Oral Dis"},{"key":"10.1016\/j.tripleo.2006.12.008_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2230.1985.tb02553.x","article-title":"Recurrent and continuous erythema multiforme\u2013a clinical and immunological study","volume":"10","author":"Leigh","year":"1985","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0190-9622(95)91435-8","article-title":"Persistent erythema multiforme: report of two new cases and review of literature","volume":"33","author":"Drago","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1034\/j.1600-0781.2003.00036.x","article-title":"Photosensitive erythema multiforme and erythema multiforme-like polymorphous light eruption","volume":"19","author":"Calzavara Pinton","year":"2003","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.tripleo.2006.12.008_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005792-198905000-00001","article-title":"Recurrent erythema multiforme","volume":"68","author":"Huff","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.tripleo.2006.12.008_bib23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2133.1993.tb00232.x","article-title":"Recurrent erythema multiforme: clinical features and treatment in a large series of patients","volume":"128","author":"Schofield","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib24","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/archderm.138.12.1547","article-title":"Recurrent erythema multiforme\/Stevens-Johnson syndrome response to mycophenolate mofetil","volume":"138","author":"Davis","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib25","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2006.12.008_bib26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1542\/peds.109.1.74","article-title":"Long-term consequences of toxic epidermal necrolysis in children","volume":"109","author":"Sheridan","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.tripleo.2006.12.008_bib27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0030-4220(76)90312-1","article-title":"Erythema multiforme","volume":"41","author":"Al-Ubaidy","year":"1976","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0030-4220(68)90010-8","article-title":"Erythema multiforme affecting the oral cavity","volume":"25","author":"Kennett","year":"1968","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0714.1995.tb01122.x","article-title":"Characteristics of the oral lesions in patients with cutaneous recurrent erythema multiforme","volume":"24","author":"Farthing","year":"1995","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.tripleo.2006.12.008_bib30","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1001\/jama.249.20.2810","article-title":"Recurrent oral erythema multiforme","volume":"249","author":"Bean","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.tripleo.2006.12.008_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000249663","article-title":"Drug-induced oral erythema multiforme","volume":"168","author":"Gebel","year":"1984","journal-title":"Dermatologica"},{"key":"10.1016\/j.tripleo.2006.12.008_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0016-5085(86)90585-8","article-title":"Gastrointestinal involvement complicating Stevens-Johnson syndrome","volume":"91","author":"Zweiban","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tripleo.2006.12.008_bib33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0031-3955(16)34430-3","article-title":"Erythema multiforme","volume":"30","author":"Edmond","year":"1983","journal-title":"Pediatr Clin N Am"},{"key":"10.1016\/j.tripleo.2006.12.008_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000249463","article-title":"Erythema multiforme (Stevens-Johnson syndrome)-charts of 123 hospitalized patients","volume":"171","author":"Nethercott","year":"1985","journal-title":"Dermatologica"},{"key":"10.1016\/j.tripleo.2006.12.008_bib35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0190-9622(84)80317-5","article-title":"Observations on drug-induced toxic epidermal necrolysis in Singapore","volume":"10","author":"Chan","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib36","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1346-8138.1997.tb02524.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease, which differs from: erythema multiforme","volume":"24","author":"Roujeau","year":"1997","journal-title":"J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00128071-200001060-00003","article-title":"Drug-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"1","author":"Fritsch","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib38","first-page":"25","article-title":"Stevens-Johnson syndrome","volume":"5","author":"Kasper","year":"2001","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.tripleo.2006.12.008_bib39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2133.1973.tb08026.x","article-title":"Subcorneal pustules in erythema multiforme","volume":"88","author":"Sneddon","year":"1973","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib40","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0190-9622(96)90732-X","article-title":"Mycoplasma pneumoniae infection is associated with Stevens-Johnson syndrome, not erythema multiforme (Von Hebra)","volume":"35","author":"Tay","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib41","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s001340051063","article-title":"Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis?","volume":"25","author":"Furubacke","year":"1999","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.tripleo.2006.12.008_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.139.1.33","article-title":"Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective non-comparative study showing no benefit on mortality or progression","volume":"139","author":"Bachot","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib43","first-page":"5","article-title":"Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome","volume":"81","author":"Ghislain","year":"2002","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.tripleo.2006.12.008_bib44","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.tripleo.2006.12.008_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archderm.136.3.323","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"136","author":"Garcia-Doval","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0305-4179(95)00140-9","article-title":"Toxic epidermal necrolysis in a burns centre: a 6-year review","volume":"22","author":"Khoo","year":"1996","journal-title":"Burns"},{"key":"10.1016\/j.tripleo.2006.12.008_bib47","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/BF02048370","article-title":"Toxic epidermal necrolysis\u2013an unusual cause of colonic perforation","volume":"36","author":"Carter","year":"1993","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.tripleo.2006.12.008_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.126.1.43","article-title":"The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis","volume":"126","author":"Chan","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib49","first-page":"123","article-title":"Toxic epidermal necrolysis","volume":"59","author":"Schwartz","year":"1997","journal-title":"Cutis"},{"key":"10.1016\/j.tripleo.2006.12.008_bib50","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archderm.127.6.839","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"127","author":"Schopf","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib51","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1525-1470.2003.03012.x","article-title":"Stevens-Johnson syndrome: a diagnostic challenge in the absence of skin lesions","volume":"20","author":"Vanfleteren","year":"2003","journal-title":"Paediatric Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib52","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0190-9622(90)70333-D","article-title":"Toxic epidermal necrolysis (Lyell syndrome)","volume":"23","author":"Roujeau","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib53","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry","volume":"149","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1440-0960.2000.00384.x","article-title":"Toxic epidermal necrolysis in Western Australia","volume":"41","author":"Brand","year":"2000","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib55","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00007611-198606000-00027","article-title":"Erythema multiforme due to herpes simplex: treatment with oral acyclovir","volume":"79","author":"Goldberg","year":"1986","journal-title":"South Med J"},{"key":"10.1016\/j.tripleo.2006.12.008_bib56","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1046\/j.1365-2133.1998.02260.x","article-title":"Erythema multiforme lesions are associated with expression of a herpes simplex virus (HSV) gene and qualitative alterations in the HSV-specific T-cell response","volume":"138","author":"Kokuba","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib57","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jmv.10502","article-title":"Detection and genotyping of human herpes simplex viruses in cutaneous lesions of erythema multiforme by nested PCR","volume":"71","author":"Sun","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib58","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/1523-1747.ep12336800","article-title":"Expression of herpes simplex virus DNA fragments located in epidermal keratinocytes and germinative cells is associated with the development of erythema multiforme lesions","volume":"109","author":"Imafuku","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib59","first-page":"372","article-title":"Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme","volume":"74","author":"Brice","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib60","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0190-9622(86)70141-2","article-title":"Oral acyclovir for the prevention of herpes-associated erythema multiforme","volume":"15","author":"Lemak","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib61","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2006.12.008_bib62","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1046\/j.1365-4362.1998.00490.x","article-title":"Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia","volume":"37","author":"Kamaliah","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib63","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/adc.83.4.347","article-title":"Diagnosis, classification, and management of erythema multiforme and Stevens-Johnsonn syndrome","volume":"83","author":"Leaute-Labreze","year":"2000","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.tripleo.2006.12.008_bib64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1440-0960.2002.00549.x","article-title":"Two unusual cases of toxic epidermal necrolysis","volume":"43","author":"Yung","year":"2002","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1188\/04.CJON.27-30","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: oncologic considerations","volume":"8","author":"Hockett","year":"2003","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.tripleo.2006.12.008_bib66","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/adc.83.4.347","article-title":"Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome","volume":"83","author":"Leaute-Labreze","year":"2000","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.tripleo.2006.12.008_bib67","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/archderm.123.9.1166","article-title":"The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell\u2019s syndrome)","volume":"123","author":"Guillaume","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib68","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0190-9622(90)70333-D","article-title":"Toxic epidermal necrolysis (Lyell syndrome)","volume":"23","author":"Roujeau","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archderm.126.1.125","article-title":"Drug-induced toxic epidermal necrolysis in developing countries","volume":"126","author":"Nanda","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib70","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2230.2004.01526.x","article-title":"Changing pattern of drug-induced toxic epidermal necrolysis in developing countries","volume":"29","author":"Kanwar","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib71","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1440-0960.1999.00342.x","article-title":"Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"40","author":"Wong","year":"1999","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib72","first-page":"428","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"1","author":"Chung","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.tripleo.2006.12.008_bib73","first-page":"478","article-title":"Stevens-Johnson syndrome and pulmonary infection by Mycoplasma pneumonia","volume":"58","author":"Larregue","year":"1982","journal-title":"Sem Hop"},{"key":"10.1016\/j.tripleo.2006.12.008_bib74","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0002-9343(85)90048-8","article-title":"Stevens-Johnson syndrome due to Mycoplasma pneumoniae in an adult","volume":"79","author":"Kalb","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.tripleo.2006.12.008_bib75","first-page":"449","article-title":"Erythema multiforme associated with an outbreak of Mycoplasma pneumoniae function","volume":"106","author":"Salmon","year":"1993","journal-title":"N Z Med J"},{"key":"10.1016\/j.tripleo.2006.12.008_bib76","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/000992289103000107","article-title":"Mycoplasma pneumoniae infections and Stevens-Johnson syndrome","volume":"30","author":"Levy","year":"1991","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.tripleo.2006.12.008_bib77","first-page":"286","article-title":"Toxic epidermal necrolysis and mixed histiolymphocytic lymphoma","volume":"28","author":"Stawiski","year":"1981","journal-title":"Cutis"},{"key":"10.1016\/j.tripleo.2006.12.008_bib78","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1046\/j.1365-2141.2002.03499.x","article-title":"Stevens-Johnson syndrome after treatment with STI571: a case report","volume":"117","author":"Hsiao","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib79","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1525-1470.2002.00002.x","article-title":"Stevens-Johnson syndrome developing in a girl with systemic lupus erythematosus on high-dose corticosteroid therapy","volume":"19","author":"Samimi","year":"2002","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib80","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1023\/A:1012351231143","article-title":"Stevens-Johnson Syndrome and cholestatic hepatitis","volume":"46","author":"Morelli","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.tripleo.2006.12.008_bib81","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1346-8138.1997.tb02308.x","article-title":"Toxic epidermal necrolysis possibly linked to hyperacute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"24","author":"Takeda","year":"1997","journal-title":"J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00015550310002611","article-title":"Severe cutaneous reactions associated with the use of human immunodeficiency virus medications","volume":"83","author":"Rotunda","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib83","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/jinf.2001.0902","article-title":"Toxic epidermal necrolysis induced by nevirapine therapy: description of two cases and review of the literature","volume":"43","author":"Cattelan","year":"2001","journal-title":"J Infect"},{"key":"10.1016\/j.tripleo.2006.12.008_bib84","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0140-6736(91)91046-W","article-title":"Adverse reactions to co-trimoxazole in HIV infection","volume":"338","author":"Van der Ven","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.tripleo.2006.12.008_bib85","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0190-9622(92)70082-Q","article-title":"Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus","volume":"26","author":"Saiag","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib86","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-4362.2002.01554.x","article-title":"Toxic epidermal necrolysis in a pregnant, HIV-infected woman","volume":"41","author":"Pacheco","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib87","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.0022-202X.2005.23712.x","article-title":"CD34+ cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM)","volume":"124","author":"Ono","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D37V35W30D","article-title":"Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component","volume":"9","author":"Aurelian","year":"2003","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.tripleo.2006.12.008_bib89","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1523-1747.1999.00754.x","article-title":"Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-gamma is expressed in HAEM lesions and tumor necrosis factor-alpha in drug-induced erythema multiforme lesions","volume":"113","author":"Kokuba","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib90","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archderm.138.8.1027","article-title":"CC and CXC chemokines are differentially expressed in erythema multiforme in vivo","volume":"138","author":"Spandau","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib91","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.181.1.169","article-title":"Autoantibodies to desmoplakin I and II in patients with erythema multiforme","volume":"181","author":"Foedinger","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.tripleo.2006.12.008_bib92","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1523-1747.1998.00328.x","article-title":"Erythema multiforme associated human autoantibodies against desmoplakin II and I: biochemical characterization and passive transfer studies into newborn mice","volume":"111","author":"Foedinger","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib93","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0190-9622(89)70235-8","article-title":"Epidermal autoantibodies in erythema multiforme","volume":"21","author":"Matsuoka","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib94","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","article-title":"Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis","volume":"134","author":"Paul","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib95","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64284-8","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand","volume":"162","author":"Abe","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib96","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archderm.130.5.598","article-title":"Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine","volume":"130","author":"Friedmann","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib97","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2133.1995.tb05016.x","article-title":"CD8+ dermal T-cells from a sulfamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes","volume":"132","author":"Hertl","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib98","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archderm.123.9.1171","article-title":"Genetic susceptibility to toxic epidermal necrolysis","volume":"123","author":"Roujeau","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib99","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archderm.129.4.466","article-title":"Cutaneous T-cell recruitment in toxic epidermal necrolysis","volume":"129","author":"Correia","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01119.x","article-title":"Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells, which express human natural killer (NK) inhibitory receptors","volume":"119","author":"Le Cleach","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib101","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1067\/mjd.2002.120473","article-title":"Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis","volume":"47","author":"Correia","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib102","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib103","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archderm.139.1.39","article-title":"Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: the University of Miami experience","volume":"139","author":"Trent","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1523-1747.2000.00037.x","article-title":"Death receptors in cutaneous biology and disease","volume":"115","author":"Wehrli","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/scientificamerican0592-68","article-title":"Biological roles of nitric oxide","volume":"266","author":"Snyder","year":"1992","journal-title":"Sci Am"},{"key":"10.1016\/j.tripleo.2006.12.008_bib106","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1182\/blood.V91.11.4311","article-title":"Caspase activation is required for nitric oxide-mediated, CD95 (APO-1\/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells","volume":"91","author":"Chlichlia","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.tripleo.2006.12.008_bib107","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00000372-199704000-00005","article-title":"Erythema multiforme and toxic epidermal necrolysis: a comparative study","volume":"19","author":"Paquet","year":"1997","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib108","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2133.1976.tb07010.x","article-title":"Histopathological spectrum of erythema multiforme","volume":"95","author":"Bedi","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib109","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1523-1747.2001.00235.x","article-title":"Interaction of HSV-1 infected peripheral blood mononuclear cells with cultured dermal microvascular endothelial cells: a potential model for the pathogenesis of HSV-1 induced erythema multiforme","volume":"116","author":"Larcher","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib110","first-page":"36","article-title":"Eosinophils in skin lesions of erythema multiforme","volume":"113","author":"Patterson","year":"1989","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.tripleo.2006.12.008_bib111","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0190-9622(84)80090-0","article-title":"Erythema multiforme: clinical, histopathologic, and immunologic study","volume":"10","author":"Howland","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib112","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9440(10)65279-0","article-title":"Epithelial hyperproliferation and transglutaminase 1 gene expression in Stevens-Johnson syndrome conjunctiva","volume":"154","author":"Nishida","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib113","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1365-4362.1999.00792.x","article-title":"The diagnostic role of the in vitro drug-induced interferon-gamma release test in Stevens-Johnson syndrome","volume":"38","author":"Halevy","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib114","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0536.1996.tb02364.x","article-title":"Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"35","author":"Wolkenstein","year":"1996","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.tripleo.2006.12.008_bib115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000018320","article-title":"Tropical-wood-induced bullous erythema multiforme","volume":"200","author":"Shimizu","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.tripleo.2006.12.008_bib116","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1345\/aph.19064","article-title":"Toxic epidermal necrolysis associated with acetaminophen ingestion","volume":"34","author":"Halevi","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.tripleo.2006.12.008_bib117","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/000155599750011633","article-title":"In vitro release of interferon-gamma and macrophage migration inhibition factor in drug-induced urticaria and angioedema","volume":"79","author":"Livni","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib118","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-102-5-632","article-title":"Post-herpetic erythema multiforme prevented with prophylactic oral acyclovir","volume":"102","author":"Green","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tripleo.2006.12.008_bib119","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0163-4453(87)93300-7","article-title":"Successful use of oral acyclovir to prevent herpes simplex-associated erythema multiforme","volume":"15","author":"Lynn","year":"1987","journal-title":"J Infect"},{"key":"10.1016\/j.tripleo.2006.12.008_bib120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2500\/108854195778666847","article-title":"Virus induced erythema multiforme and Stevens-Johnson syndrome","volume":"16","author":"Choy","year":"1995","journal-title":"Allergy Proc"},{"key":"10.1016\/j.tripleo.2006.12.008_bib121","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2500\/108854196778645056","article-title":"Recurrent Stevens-Johnson syndrome secondary to herpes simplex: a follow up on a successful management program","volume":"17","author":"Cheriyan","year":"1996","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.tripleo.2006.12.008_bib122","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.1995.tb05024.x","article-title":"A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme","volume":"132","author":"Tatnall","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib123","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s100670200111","article-title":"Arthritis associated with recurrent erythema multiforme responding to oral acyclovir","volume":"21","author":"Molnar","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib124","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archderm.134.7.876","article-title":"Recurrent erythema multiforme unresponsive to acyclovir prophylaxis and responsive to valacyclovir continuous therapy","volume":"134","author":"Kerob","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.1981.tb00044.x","article-title":"Topical treatment of recurrent herpes simplex and post-herpetic erythema multiforme with low concentrations of zinc sulphate solution","volume":"104","author":"Brody","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib126","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century","volume":"23","author":"Palmieri","year":"2002","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.tripleo.2006.12.008_bib127","first-page":"815","article-title":"Drug-induced toxic epidermal necrolysis with involvement of the intestinal and respiratory tract","volume":"51","author":"Jackel","year":"2002","journal-title":"Anaesthesist"},{"key":"10.1016\/j.tripleo.2006.12.008_bib128","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/00006534-199809040-00014","article-title":"Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center","volume":"102","author":"McGee","year":"1998","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.tripleo.2006.12.008_bib129","first-page":"273","article-title":"Burn center care for patients with toxic epidermal necrolysis","volume":"180","author":"Kelemen","year":"1995","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.tripleo.2006.12.008_bib130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0190-9622(85)70207-1","article-title":"Acute disseminated epidermal necrolysis types 1, 2, and 3","volume":"13","author":"Ruiz-Maldonado","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib131","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2340\/0001555571171172","article-title":"Toxic epidermal necrolysis in patients receiving glucocorticosteroids","volume":"71","author":"Rzany","year":"1991","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib132","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archderm.123.9.1156","article-title":"Treatment of toxic epidermal necrolysis","volume":"123","author":"Revuz","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib133","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00000658-198611000-00001","article-title":"Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids","volume":"204","author":"Halebian","year":"1986","journal-title":"Ann Surg"},{"key":"10.1016\/j.tripleo.2006.12.008_bib134","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1378\/chest.98.2.331","article-title":"Erythema multiforme and Stevens-Johnson syndrome","volume":"98","author":"Patterson","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.tripleo.2006.12.008_bib135","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1542\/peds.108.5.1162","article-title":"Treatment of extensive toxic epidermal necrolysis in children","volume":"108","author":"Spies","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.tripleo.2006.12.008_bib136","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-3476(89)80736-X","article-title":"Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"115","author":"Prendiville","year":"1989","journal-title":"J Pediatr"},{"key":"10.1016\/j.tripleo.2006.12.008_bib137","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0190-9622(91)70176-3","article-title":"Toxic epidermal necrolysis: a review","volume":"25","author":"Avakian","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib138","first-page":"340","article-title":"Toxic epidermal necrolysis, a systemic and dermatologic disorder best treated with standard treatment protocols in burn intensive care units without the prolonged use of corticosteroids","volume":"180","author":"Herndon","year":"1995","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.tripleo.2006.12.008_bib139","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archderm.131.6.669","article-title":"Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy","volume":"131","author":"Guibal","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib140","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0190-9622(08)80969-3","article-title":"Efficacy of cyclophoshamide in toxic epidermal necrolysis: clinical and pathophysiologic aspects","volume":"25","author":"Heng","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib141","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00007611-199610000-00015","article-title":"Cyclophosphamide in the treatment of toxic epidermal necrolysis","volume":"89","author":"Frangogiannis","year":"1996","journal-title":"South Med J"},{"key":"10.1016\/j.tripleo.2006.12.008_bib142","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1365-2133.1998.2576n.x","article-title":"Severe bullous drug reactions treated successfully with cyclophosphamide","volume":"139","author":"Trautmann","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib143","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","article-title":"Treatment of toxic epidermal necrolysis with cyclosporin A","volume":"48","author":"Arevalo","year":"2000","journal-title":"J Trauma"},{"key":"10.1016\/j.tripleo.2006.12.008_bib144","first-page":"31","article-title":"Toxic epidermal necrolysis in a patient with severe aplastic anemia treated with cyclosporin A and G-CSF","volume":"32","author":"Robak","year":"2001","journal-title":"J Med"},{"key":"10.1016\/j.tripleo.2006.12.008_bib145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000018378","article-title":"Dapsone-responsive persistent erythema multiforme","volume":"200","author":"Mahendran","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.tripleo.2006.12.008_bib146","first-page":"329","article-title":"Persistent erythema multiforme associated with chronic hepatitis C virus infection","volume":"124","author":"Berard","year":"1997","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib147","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1046\/j.1365-2133.2000.03566.x","article-title":"Recurrent erythema multiforme and chronic hepatitis C: efficacy of interferon alpha","volume":"142","author":"Dumas","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib148","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","article-title":"Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis","volume":"352","author":"Wolkenstein","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.tripleo.2006.12.008_bib149","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2133.2002.46833.x","article-title":"Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis","volume":"146","author":"Fischer","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib150","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2005.06.029","article-title":"Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment","volume":"116","author":"Hunger","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib151","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.139.1.26","article-title":"Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases","volume":"139","author":"Prins","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib152","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaad.2003.07.017","article-title":"Intravenous immunoglobulin prophylaxis for recurrent Stevens-Johnson syndrome","volume":"50","author":"Hebert","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib153","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1067\/mjd.2002.127249","article-title":"Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children","volume":"47","author":"Tristani-Firouzi","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib154","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejim.2004.04.007","article-title":"Nevirapine-induced toxic epidermal necrolysis and toxic hepatitis treated successfully with a combination of intravenous immunoglobulins and N-acetylcysteine","volume":"15","author":"Claes","year":"2004","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.tripleo.2006.12.008_bib155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000051702","article-title":"Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience","volume":"203","author":"Stella","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.tripleo.2006.12.008_bib156","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0305-4179(01)00005-5","article-title":"Treatment of drug-induced toxic epidermal necrolysis (Lyell\u2019s syndrome) with intravenous human immunoglobulins","volume":"27","author":"Paquet","year":"2001","journal-title":"Burns"},{"key":"10.1016\/j.tripleo.2006.12.008_bib157","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.BCR.0000105096.93526.27","article-title":"Toxic epidermal necrolysis: does immunoglobulin make a difference?","volume":"25","author":"Brown","year":"2004","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.tripleo.2006.12.008_bib158","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00130832-200308000-00006","article-title":"Intravenous immunoglobulins in the treatment of severe drug eruptions","volume":"3","author":"Bachot","year":"2003","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib159","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0140-6736(91)93395-P","article-title":"High-dose intravenous IgG treatment and renal function","volume":"337","author":"Schifferli","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.tripleo.2006.12.008_bib160","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1093\/ndt\/13.9.2182","article-title":"The renal risks of high-dose intravenous immunoglobulin treatment","volume":"13","author":"Stahl","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.tripleo.2006.12.008_bib161","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1744-9987.1998.tb00127.x","article-title":"The efficacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: two case reports","volume":"2","author":"Matsumoto","year":"1998","journal-title":"Ther Apher"},{"key":"10.1016\/j.tripleo.2006.12.008_bib162","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0190-9622(99)70497-4","article-title":"Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis","volume":"40","author":"Egan","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib163","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1526-0968.2002.00409.x","article-title":"Plasma exchange in patients with toxic epidermal necrolysis","volume":"6","author":"Bamichas","year":"2002","journal-title":"Ther Apher"},{"key":"10.1016\/j.tripleo.2006.12.008_bib164","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/archderm.121.12.1548","article-title":"Plasmapheresis in severe drug-induced toxic epidermal necrolysis","volume":"121","author":"Kamanabroo","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib165","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bjps.2004.12.007","article-title":"Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report","volume":"58","author":"Lissia","year":"2005","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.tripleo.2006.12.008_bib166","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1067\/mjd.2002.118557","article-title":"Toxic epidermal necrolysis treated with N-acetylcysteine","volume":"46","author":"Velez","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib167","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000048174","article-title":"Intravenous ulinastatin therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis in pediatric patients","volume":"127","author":"Inamo","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib168","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/000992280003901201","article-title":"Toxic epidermal necrolysis in children-an update","volume":"39","author":"Ringheanu","year":"2000","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.tripleo.2006.12.008_bib169","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/000992289002900609","article-title":"Esophageal stenosis following Stevens-Johnson syndrome","volume":"29","author":"Rottermann","year":"1990","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.tripleo.2006.12.008_bib170","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0161-6420(95)30811-1","article-title":"Analysis of the acute ophthalmic manifestations of the erythema multiforme\/ Stevens-Johnson syndrome\/toxic epidermal necrolysis disease spectrum","volume":"102","author":"Power","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.tripleo.2006.12.008_bib171","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s001340050492","article-title":"Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study","volume":"23","author":"Lebargy","year":"1997","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.tripleo.2006.12.008_bib172","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00002018-200225130-00006","article-title":"Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years\u2019 experience","volume":"25","author":"Forman","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.tripleo.2006.12.008_bib173","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2230.2003.01285_8.x","article-title":"Toxic epidermal necrolysis complicated by delayed mucosal healing and haemorrhagic mucositis","volume":"28","author":"Dawe","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.tripleo.2006.12.008_bib174","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000070938","article-title":"Dermatological and ophthalmological sequels in toxic epidermal necrolysis","volume":"207","author":"Magina","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.tripleo.2006.12.008_bib175","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1055\/s-2003-38765","article-title":"Oesophageal stricturing secondary to adult Stevens-Johnson syndrome: similarities in presentation and management to corrosive injury","volume":"35","author":"Agrawal","year":"2003","journal-title":"Endoscopy"},{"key":"10.1016\/j.tripleo.2006.12.008_bib176","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210406010043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210406010043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T14:39:33Z","timestamp":1707662373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210406010043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":176,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S1079210406010043"],"URL":"https:\/\/doi.org\/10.1016\/j.tripleo.2006.12.008","relation":{},"ISSN":["1079-2104"],"issn-type":[{"value":"1079-2104","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}